Defective glycosylation in congenital muscular dystrophies

被引:106
作者
Muntoni, F [1 ]
Brockington, M [1 ]
Torelli, S [1 ]
Brown, SC [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Paediat, Dubowitz Neuromuscular Unit, London W12 0NN, England
关键词
alpha-dystroglycan; glycosylation; glycosyltransferases; muscular dystrophy; neuronal migration;
D O I
10.1097/00019052-200404000-00020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review The recent identification of mutations in five genes coding for proteins with putative or demonstrated glycosyltransferase activity has shed light on a novel mechanism responsible for muscular dystrophy. Abnormal glycosylation of alpha-dystroglycan appears to be a common finding in all these conditions. Surprisingly, the disease severity due to mutations in several of these genes is extremely variable. This article provides an overview of the clinical, biochemical and genetic advances that have been made over the last year in this field. Recent findings Mutations in the human LARGE gene, a putative glycosyltransferase mutated in the myodystrophy mouse, have now been identified in a form of human muscular dystrophy. In addition, the clinical variability of patients with mutations in the genes encoding fukutin, protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1 and the fukutin-related protein has been significantly expanded. Disease severity in patients with mutations in the gene encoding the fukutin-related protein varies from a severe prenatal form of congenital muscular dystrophy with cobblestone lissencephaly and structural eye defects to a mild form of limb-girdle muscular dystrophy with onset in adult life and neither brain nor eye involvement. Summary Glycosylation disorders represent a rapidly growing and common group of muscular dystrophies. Accurate genetic diagnosis can now be made for five forms, and it is anticipated that several other variants will eventually fall into these categories.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 36 条
  • [11] Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Largemyd mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders
    Holzfeind, PJ
    Grewal, PK
    Reitsamer, HA
    Kechvar, J
    Lassmann, H
    Hoeger, H
    Hewitt, JE
    Bittner, RE
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (21) : 2673 - 2687
  • [12] Profound skeletal muscle depletion of α-dystroglycan in Walker-Warburg syndrome
    Jiménez-Mallebrera, C
    Torelli, S
    Brown, SC
    Feng, L
    Brockington, M
    Sewry, CA
    De Bernabé, DBV
    Muntoni, F
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2003, 7 (03) : 129 - 137
  • [13] Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of α-dystroglycan
    Longman, C
    Brockington, M
    Torelli, S
    Jimenez-Mallebrera, C
    Kennedy, C
    Khalil, N
    Feng, L
    Saran, RK
    Voit, T
    Merlini, L
    Sewry, CA
    Brown, SC
    Muntoni, F
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (21) : 2853 - 2861
  • [14] Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease
    Manya, H
    Sakai, K
    Kobayashi, K
    Taniguchi, K
    Kawakita, M
    Toda, T
    Endo, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (01) : 93 - 97
  • [15] Glycobiology of neuromuscular disorders
    Martin, PT
    Freeze, HH
    [J]. GLYCOBIOLOGY, 2003, 13 (08) : 67R - 75R
  • [16] Protein glycosylation in disease: new insights into the congenital muscular dystrophies
    Martin-Rendon, E
    Blake, DJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (04) : 178 - 183
  • [17] Phenotypic spectrum associated with mutations in the fukutin-related protein gene
    Mercuri, E
    Brockington, M
    Straub, V
    Quijano-Roy, S
    Yuva, Y
    Herrmann, R
    Brown, SC
    Torelli, S
    Dubowitz, V
    Blake, DJ
    Romero, NB
    Estournet, B
    Sewry, CA
    Guicheney, P
    Voit, T
    Muntoni, F
    [J]. ANNALS OF NEUROLOGY, 2003, 53 (04) : 537 - 542
  • [18] Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function
    Michele, DE
    Campbell, KP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) : 15457 - 15460
  • [19] Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies
    Michele, DE
    Barresi, R
    Kanagawa, M
    Saito, F
    Cohn, RD
    Satz, JS
    Dollar, J
    Nishino, I
    Kelley, RI
    Somer, H
    Straub, V
    Mathews, KD
    Moore, SA
    Campbell, KP
    [J]. NATURE, 2002, 418 (6896) : 417 - 422
  • [20] Targeting dystroglycan in the brain
    Montanaro, F
    Carbonetto, S
    [J]. NEURON, 2003, 37 (02) : 193 - 196